Hantavirus pulmonary syndrome

Heart and Lung: Journal of Acute and Critical Care

Volumn 27, Issue 1, 1998, Pages 51-57

  Simpson, Steven Q ^a,b,c  

^a University of New Mexico ^*

^b UNIVERSITY OF NEW MEXICO   (United States)

^c Cardiopulmonary Section   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DOBUTAMINE; DOPAMINE; LACTATE DEHYDROGENASE; LACTIC ACID; LIVER ENZYME;

ARTIFICIAL VENTILATION; CAPILLARY LEAK SYNDROME; CARDIOGENIC SHOCK; CLINICAL FEATURE; DISEASE COURSE; DISEASE TRANSMISSION; EXTRACORPOREAL OXYGENATION; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEMODYNAMICS; HOSPITAL INFECTION; HUMAN; LUNG CAPILLARY; LUNG EDEMA; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY;

EID: 0031892367     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9563(98)90069-3     Document Type: Article

References (36)

1. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994;330:949-55.
2. Elliott LH, Ksiazek TG, Rollin PE, Spiropoulou CF, Morzunov S, Monroe M, et al. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg 1994;51:102-8.
3. Feldmann H, Sanchez A, Morzunov S, Spiropoulou CF, Rollin PE, Ksiazek TG, et al. Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantaviral pulmonary syndrome. Virus Res 1993;30:351-67.
4. Spiropoulou CF, Morzunov S, Feldmann H, Sanchez A, Peters Cl, Nichol ST. Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virol 1994;200:715-23.
5. Hallin GW, Simpson SQ, Crowell RE, et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 1996;24:252-8.
6. Peters CJ, Johnson KM. Viral hemorrhagic fevers. In: Hoeprich PD, Jordan MC, Ronald AR, editors. Infectious diseases. 5th ed. Philadelphia: JB Lippincott;1994.p.924-9.
7. Peters CJ, Johnson KM. California encephalitis viruses, hantaviruses, and other Bunyaviridae. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious disease. 4th ed. New York: Churchill Livingston; 1995.p.1567-72.
8. McCormick JB. Crimean-Congo hemorrhagic fever (CCHF). In: Strickland GT, editor. Hunter's tropical medicine. 7th ed. Philadelphia: WB Saunders; 1991.p.248-54.
9. McKee KT Jr, LeDuk JW, Peters CJ. Hantaviruses. In: Belshe RB, editor. Textbook of human virology. 2nd ed. St. Louis: Mosby; 1991.p.615-32.
10. Hjelle B, Jenison S, Torrez-Martinez N, et al. A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses. J Virol 1994;68:592-6.
11. CDC. Hantavirus pulmonary syndrome - Virginia, 1993. MMWR Morb Mortal Wkly Rep 1994;43:876-7.
12. CDC. Update: hantavirus-associated illness - North Dakota, 1993. MMWR Morb Mortal Wkly Rep 1993;42:707.
13. CDC. Newly identified hantavirus - Florida, 1994. MMWR Morb Mortal Wkly Rep 1994;43:99-105.
14. CDC. Hantavirus pulmonary syndrome - northeastern United States, 1994. MMWR Morb Mortal Wkly Rep 1994;43:548-9.
15. Hjelle B, Krolikowski J, Torrez-Martinez N, Chavez-Giles F, Vanner C, Laposata E. A phylogenetically distinct hantavirus implicated in a case of hantavirus pulmonary syndrome in the northeastern United States. J Med Virol. In press.
16. Morzunov SP, Feldmann H, Spiropoulou CF, et al. A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana. J Virol 1995;69:1980-3.
17. Enria D, Padula P, Segura EL, Pini N, Edelstein A, Riva Posse C, et al. Hantavirus pulmonary syndrome in Argentina: possibility of person to person transmission. Medicina 1996;56:709-11.
18. Lopez N, Padula P, Rossi C, Lazare ME, Franze-Fernandez MT. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 1996; 220:223-6.
19. Yamada T, Hjelle B, Lanzi R, Morris C, Anderson B, Jenison S. Antibody responses to Four Corners hantavirus infections in the deer mouse (Peromyscus maniculatus): identification of an immunodominant region of the nucleocapsid protein. J Virol 1995;69:1939-43.
20. Hjelle B, Torrez-Martinez N, Koster FT, Jay M, Ascher MS, Brown T, et al. Epidemiologie linkage of rodent and human hantavirus genomic sequences in case investigations of hantavirus pulmonary syndrome. J Infect Dis 1996;173:781-6.
21. Simpson SQ, Jones PW, Davies PDO, et al. Social impact of respiratory infections. Chest 1995;108 (suppl):63S-69S.
22. Dull SM, Brillman JC, Simpson SQ, Sklar DP. Hantavirus pulmonary syndrome: recognition and emergency department management. Ann Emerg Med 1994;24:530-6.
23. Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am J Path 1995;146:552-79.
24. Nolte KB, Feddersen RM, Foucar K, et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 1995;26:110-20.
25. Crowley MR, Kessler R, Katz RW, Simpson SQ, Levy HL, Hallin GW, et al. Successful treatment of severe hantavirus pulmonary syndrome with ECMO. Crit Care Medicine. In press.
26. Ketai LH, Williamson MR, Telepak RJ, et al. Hantavirus pulmonary syndrome: radiographic findings in 16 patients. Radiol 1994;191:665-8.
27. Hjelle B, Spiropoulou CF, Torrez-Martinez N, Morzunov S, Peters CJ, Nichol ST. Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome. J Infect Dis 1994;170:1013-7.
28. Jenison S, Yamada T, Morris C, et al. Characterization of human antibody responses to Four Corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol 1994;68:3000-6.
29. Fein A, Grossman RF, Jones JG, et al. The value of edema fluid protein measurement in patients with pulmonary edema. Am J Med 1979;67:32-8.
30. Bone RC, Fisher CJ, Clemmer TP, et al. Sepsis syndrome: a valid clinical entity. Crit Care Med 1989;17:389-93.
31. Parker MM, Parrillo JE. Septic shock - hemodynamics and pathogenesis. JAMA 1983;250:3324-7.
32. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-7.
33. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W. A circulating myocardial depressant substance in humans with septic shock: septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985;76:1539-53.
34. Sibbald WJ, Driedger AA, Cunningham DG, Cheung H. Right and left ventricular performance in acute hypoxemic respiratory failure. Crit Care Med 1986;14:852-7.
35. Vitek CR, Breiman RF, Ksiazek TG, Rollin PE, McLaughlin JC, Umland ET, et al. Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis 1996;22:824-6.
36. Wells RM, Estani SS, Yadon ZE, Enria D, Padula P, Pini N, et al. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Emerging Infect Dis 1997;3:171-4.